Showing results (1-10 of 61) with videos related to
Sort By:
Pageof 7
Endocrinology and Metabolism (Seoul, Korea)|October 16, 2024
Long-Term Antithyroid Drug Therapy in Smoldering or Fluctuating-Type Graves' Hyperthyroidism with Potassium IodideKen OkamuraPigment Cell & Melanoma Research|September 24, 2020
Current landscape of Oculocutaneous Albinism in JapanKen Okamura, Tamio SuzukiEconomics Letters|September 21, 2020
Benford's Law and COVID-19 reportingChristoffer Koch, Ken OkamuraThe Journal of Dermatology|October 23, 2025
Genetic Pigmentary Disorders: From Molecular Mechanisms to Clinical ManifestationsKen Okamura, Tamio SuzukiJournal of Dermatological Science|January 31, 2025
Genetics and epigenetics in vitiligoKen Okamura, Tamio SuzukiEuropean Thyroid Journal|September 6, 2024
Graves' hyperthyroidism treated with potassium iodide: early response and after 2 years of follow-upMegumi Fujikawa, Ken OkamuraNihon Rinsho. Japanese Journal of Clinical Medicine|December 13, 2006
[Painless thyroiditis]Ken Okamura, Megumi Fujikawa, Sachiko BandaiThe Journal of Investigative Dermatology|March 23, 2021
Gaining Insight into Vitiligo Genetics through the Lens of a Large Epidemiologic StudyKen Okamura, Manuel Garber, John E HarrisThe Journal of Dermatology|August 10, 2020
Expression of discoidin domain receptor 1 and E-cadherin in epidermis affects melanocyte behavior in rhododendrol-induced leukoderma mouse modelYuko Abe, Yutaka Hozumi, Ken Okamura, et al.Endocrine Journal|April 3, 2020
Clinical experience of treating Graves' hyperthyroidism complicated with malignancy-The possible role of potassium iodide for avoiding the risk of thionamide-associated neutropeniaKen Okamura, Sachiko Bandai, Megumi Fujikawa, et al.Pageof 7